Guy-Charles Fanneau de la Horie
Directeur/Bestuurslid bij GENFLOW BIOSCIENCES PLC
Vermogen: 9 861 $ op 30-06-2024
Actieve functies van Guy-Charles Fanneau de la Horie
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENFLOW BIOSCIENCES PLC | Directeur/Bestuurslid | 29-06-2022 | - |
| Independent Dir/Board Member | 29-06-2022 | - | |
| PHARNEXT SCA | Directeur/Bestuurslid | 10-07-2023 | - |
Loopbaan van Guy-Charles Fanneau de la Horie
Eerdere bekende functies van Guy-Charles Fanneau de la Horie
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PHERECYDES PHARMA | Algemeen Directeur | 01-04-2016 | 19-05-2022 |
| NEOVACS | Directeur/Bestuurslid | 22-09-2011 | 17-10-2013 |
| Algemeen Directeur | 11-04-2007 | 17-10-2013 | |
PathoQuest SAS
 PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Algemeen Directeur | - | - |
| NANOBIOTIX | Directeur/Bestuurslid | - | - |
Opleiding van Guy-Charles Fanneau de la Horie
| INSEAD | Masters Business Admin |
Statistieken
Internationaal
| Frankrijk | 7 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| NEOVACS | Health Technology |
| NANOBIOTIX | Health Technology |
| GENFLOW BIOSCIENCES PLC | Health Technology |
| PHARNEXT SCA | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Health Technology |
